Companies

Coeptis Therapeutics Holdings, Inc.

COEP, COEPW · CIK 0001759186 · operating

$0.01-0.85%Last updated Feb 27, 8:54 PM

Key Statistics

Valuation

Market Cap
P/E
Fwd P/E
PEG
P/S
P/B
EV/EBITDA
EV/Rev

Profitability

Gross Margin
Op. Margin
Net Margin
ROE-341.50%
ROA-122.10%
FCF Margin

Financial Health

Current Ratio0.23
Debt/Equity1.58
Free Cash Flow-$6.65M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth-580.72%
Beta
52W High$0.012
52W Low$0.009

About Coeptis Therapeutics Holdings, Inc.

# Coeptis Therapeutics Holdings, Inc.

Based on available data, Coeptis Therapeutics Holdings, Inc. operates within the financial services sector and is incorporated in Delaware with listing on Nasdaq. The company's specific business operations, primary product lines, and revenue-generating segments are not sufficiently detailed in the provided information to enable a comprehensive description of its core activities.

The company's scale, including employee count, current revenue tier, and geographic footprint, cannot be accurately characterized without additional operational data. Further research into regulatory filings, earnings reports, or business disclosures would be necessary to establish concrete details regarding the company's market position and business structure.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-5.65$-5.65-580.7%
2023$-0.83$-0.83+68.4%
2022$-2.63$-2.63-262.3%
2021$1.62
2020

Annual Reports (10-K) · 5 filings

Report DateFiledAccession Number
2024-12-312025-03-280001683168-25-001942SEC ↗
2023-12-312024-03-260001683168-24-001685SEC ↗
2022-12-312023-03-290001683168-23-001850SEC ↗
2021-12-312022-04-080001213900-22-018778SEC ↗
2020-12-312021-03-310001213900-21-019200SEC ↗